Clinical trial
Effect of Phosphate Binders on FGF-23 During Calcitriol Administration in CKD Stage 3 Patients
NCT01748396 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Phosphate Binders on FGF-23 During Calcitriol Administration in CKD Stage 3 Patients
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- January 31, 2013
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease stage 3